Puma Biotechnology Reports Third Quarter 2018 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- S&P, Nasdaq drop on tech selloff as concerns about hawkish Fed, AI spending mount
- Chip stocks plunge, but bargain-hunters stem losses in other tech names
- Oil prices steady as investors focus on Hormuz flows after peace talks
- South Korea leveraged ETF crisis sparks global chip selloff
- Trump announces nuclear deal with Iran, lifts Hormuz blockade
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- 'Equal and opposite': BTIG's Krinsky sees sharp reversal ahead for chip stocks
Puma Biotech (PBYI) Reports Q3 EPS of $0.17
November 1, 2018 4:17 PM EDTPuma Biotech (NASDAQ: PBYI) reported Q3 EPS of $0.17, versus ($1.36) reported last year. Revenue for the quarter came in at $62.6 million versus the consensus estimate of $57.94 million.
For earnings history and earnings-related data on Puma Biotech (PBYI) click here.
... More